fbpx
Industry Session
Biomarkers for decision making in heart failure
Sunday July 12, 2020: 7:00PM – 8:30 PM CST (GMT +8)
PROF. EVANGELOS GIANNITSIS
(Germany)
DR. MARKUS ANKER
(Germany)
PROF. STEPHAN VON HAEHLING
(Germany)
anker
PROF. STEFAN ANKER
(Germany)
coats
PROF. ANDREW COATS
(UK)
Co-chairs: Andrew Coats, Stefan Anker
AGENDA:
  • Introduction – Stefan Anker
  • Biomarkers in the management of heart failure with Covid 19 – Markus Anker
  • Procalcitonin in acute HF patients – Stephan von Haehling
  • Biomarkers for infarct diagnosis in HF – Evangelos Giannitsis
  • Panel discussion
LEARNING OBJECTIVES:
  • Review the role of biomarkers in the management of patients with heart failure and specifically those with Covid-19
  • Understand the role of procalcitonin (PCT) and PCT‐guided antibiotic therapy in acute heart failure
  • Assess the latest data about the role biomarkers for infact diagnosis in heart failure
Organized by Charité and supported by an educational grant provided by Thermo Fisher.
Looking to register a group of 10 or more? contact: “[email protected]”.

Thank You!